Insider trading

Period: 12 months + Add filter
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

60,169 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

60,169 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

60,169 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

60,169 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
60,169 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
60,169 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

60,169 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
27 Apr 2026
Pinner Jeffrey Tsvi Chief Technology Officer
Sold on a plan 3×
$489.69K 5,835 at 83.92
32.4%
Planned (10b5-1)
27 Apr 2026
DONNAN JOHN MALCOLM EVP, CAO and GC
Sold at will
$488.81K 2,743 at 178.20
8.5%
Not planned
27 Apr 2026
STETZ MATTIAS Chief Operating Officer · indirect
Sold on a plan
$481.12K 20,000 at 24.06
15.9%
Planned (10b5-1)
27 Apr 2026
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan 2×
$445.34K 2,182 at 204.10
1.5%
Planned (10b5-1)
27 Apr 2026
Fendley Steven S. President, US Division
Sold on a plan
$431.45K 7,000 at 61.64
2.0%
Planned (10b5-1)
27 Apr 2026
Goel Rajeev K. CHIEF EXECUTIVE OFFICER
Sold on a plan
$430.14K 44,000 at 9.78
67.5%
Sold half or more
27 Apr 2026
LITTLE JAMES Executive VP Engineering
Sold at will
$427.17K 2,605 at 163.98
7.0%
Not planned
27 Apr 2026
Olivan Javier Chief Operating Officer · indirect
Sold on a plan 4×
$421.96K 629 at 670.84
21.0%
Planned (10b5-1)
27 Apr 2026
Mancini Anthony See Remarks
Sold on a plan 3×
$413.13K 3,120 at 132.41
5.4%
Planned (10b5-1)
27 Apr 2026
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan 2×
$406.86K 1,993 at 204.14
3.1%
Planned (10b5-1)
27 Apr 2026
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan 2×
$379.81K 1,861 at 204.09
0.8%
Planned (10b5-1)
27 Apr 2026
Corre Partners Management, LLC 10% owner · indirect
Sold at will 2×
$358.05K 136,165 at 2.63
26.8%
Not planned
27 Apr 2026
Barrett John Frederick 10% owner · indirect
Sold at will
$358.05K 136,165 at 2.63
2.9%
Not planned
27 Apr 2026
MILLER DOUGLAS S Director
Sold at will
$349.80K 10,000 at 34.98
5.1%
Not planned
27 Apr 2026
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan 2×
$344.52K 1,688 at 204.10
0.9%
Planned (10b5-1)
27 Apr 2026
Schmidt James F CFO, Treasurer, Secretary
Sold on a plan
$343.76K 1,241 at 277.00
100%
Sold half or more
27 Apr 2026
Harrell James A. III Pres. Global Ind. Paper Pkg. · indirect
Bought
$340.18K 6,753 at 50.37
204%
First buy on file
27 Apr 2026
Baker James C President
Bought
$339.25K 25,000 at 13.57
2.6%
27 Apr 2026
Yi Steven See Remarks
Sold on a plan
$336.24K 33,663 at 9.99
1.1%
Planned (10b5-1)
27 Apr 2026
Susi Roger E. CEO, President, Chairman · indirect
Sold on a plan 2×
$334.35K 3,750 at 89.16
0.2%
Planned (10b5-1)
27 Apr 2026
GELFOND RICHARD L Chief Executive Officer
Sold on a plan
$333.81K 8,943 at 37.33
1.2%
Planned (10b5-1)
27 Apr 2026
Sold at will
$307.83K 2,000 at 153.92
43.6%
Not planned
27 Apr 2026
Gross Joli L. SVP, Chief LGL & Sustain. Off.
Sold at will
$292.23K 306 at 954.99
5.1%
Not planned
27 Apr 2026
Nonko Eugene Director
Sold on a plan
$280.89K 27,972 at 10.04
2.8%
Planned (10b5-1)
27 Apr 2026
Nonko Eugene Director · indirect
Sold on a plan
$276.27K 27,513 at 10.04
2.1%
Planned (10b5-1)
27 Apr 2026
RUBINSTEIN JULIE President and COO
Sold on a plan
$270.90K 19,037 at 14.23
4.8%
Planned (10b5-1)
27 Apr 2026
Winters Chad VP, Chief Accounting Officer
Sold at will
$269.40K 896 at 300.67
37.0%
Not planned
27 Apr 2026
Lucas Shannon President & COO · indirect
Sold on a plan
$253.13K 13,500 at 18.75
1.0%
Planned (10b5-1)
27 Apr 2026
BAILEY VICKY A Director
Sold at will
$246.14K 4,116 at 59.80
100%
Sold half or more
27 Apr 2026
Makagon Kira President and COO
Sold on a plan 2×
$236.36K 5,870 at 40.27
2.4%
Planned (10b5-1)
27 Apr 2026
Sold on a plan
$233.36K 10,987 at 21.24
4.2%
Planned (10b5-1)
27 Apr 2026
HYLE KATHLEEN W Director
Bought
$230.00K 10,000 at 23.00
8.5%
First buy on file
27 Apr 2026
Samuel Olivier Director
Bought
$225.00K 81,818 at 2.75
opened
First buy on file
27 Apr 2026
D'Amico Andrew Director
Sold on a plan
$221.60K 800 at 277.00
100%
Sold half or more
27 Apr 2026
LARSON MATTHEW PAUL Chief Risk Officer
Sold on a plan 2×
$211.16K 11,250 at 18.77
100%
Sold half or more
27 Apr 2026
DUCHENE TODD M See remarks
Sold on a plan
$209.39K 10,000 at 20.94
0.5%
Planned (10b5-1)
27 Apr 2026
Zaremba Bruno Augusto Sacchi Pres. Finance and Operations · indirect
Sold on a plan
$209.35K 18,997 at 11.02
1.6%
Planned (10b5-1)
27 Apr 2026
Aoki Ichiro President
Sold on a plan
$201.97K 50,000 at 4.04
32.0%
Planned (10b5-1)
27 Apr 2026
Gray James D Chief Financial Officer
Bought
$199.78K 4,556 at 43.85
8.3%
First buy on file
27 Apr 2026
Trecker Kristin Senior Vice President
Sold at will
$185.30K 1,622 at 114.24
15.0%
Not planned
27 Apr 2026
Pettiti Gianluca President & COO
Sold on a plan
$185.06K 400 at 462.66
1.6%
Planned (10b5-1)
27 Apr 2026
Rosenbaum Michael George Chief Executive Officer
Sold on a plan
$165.71K 1,200 at 138.09
0.6%
Planned (10b5-1)
27 Apr 2026
MATA NATHAN L. Chief Scientific Officer
Sold on a plan 5×
$162.64K 1,000 at 162.64
11.5%
Planned (10b5-1)
27 Apr 2026
Sold on a plan
$151.49K 4,734 at 32.00
1.1%
Planned (10b5-1)
27 Apr 2026
Revel Michel CSO and Director
Bought
$150.00K 54,545 at 2.75
6.0%
First buy on file
27 Apr 2026
Sold on a plan
$148.75K 4,150 at 35.84
0.3%
Planned (10b5-1)
27 Apr 2026
Chacon Quiros Juan Jose Director · indirect
Sold at will 3×
$144.44K 2,180 at 66.26
0.2%
Not planned
27 Apr 2026
Gupta Vikram See Remarks
Sold on a plan
$143.81K 1,548 at 92.90
1.7%
Planned (10b5-1)
27 Apr 2026
Raben David Chief Medical Officer
Sold on a plan
$125.83K 5,500 at 22.88
9.0%
Planned (10b5-1)
27 Apr 2026
Bought
$111.09K 6,500 at 17.09
130%
Largest buy in 3 yrs
Showing 29,401–29,450 of 60,169. ← Newer Page 589 of 1,204 Older →